Understand hereditary HAE: https://bit.ly/44lwdcm

#HAE #Genetics #Inheritance #AngioedemaNews #Bionews

#HAE #HereditaryAngioedema #RareDisease #RareDiseaseAwareness #ChronicIllness #ChronicIllnessAwareness #SelfAdvocacy #PatientAdvocate #PatientAdvocacy #InvisibleIllness #RareDiseaseCommunity #HealthAdvocacy #SpeakUpForYourHealth #BioNews #AngioedemaNews

Navigate life with HAE: https://bit.ly/3ZB20U5

#HAE #LivingWell #PatientJourney #AngioedemaNews #Bionews

Sebetralstat Shows Promise for Younger Patients With Hereditary Angioedema Children aged 2 to 11 years with HAE may soon benefit from sebetralstat, the first oral on-demand treatment option for their age group.

The KONFIDENT-KID trial is evaluating a weight-based orally disintegrating tablet formulation in younger children, using 4 dosing tiers. Presented at the 5th #ITACA National Congress in Venice.

Read more: https://bit.ly/4bHjJQ9

#RareDisease #HereditaryAngioedema #HAE

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System BOSTON, March 30, 2026/ PRNewswire/-- Haemonetics Corporation, a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug Administration approval to expand the labeling for the VASCADE MVP ® XL venous vascular closure system to include procedures using 10-14 F...

#HAE Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

www.stocktitan.net/news/HAE/haemonetics-rec...

Plan for emergencies: https://bit.ly/4kPoVDK

#HAE #Emergency #Safety #AngioedemaNews #Bionews

Get tips from real caregivers: https://bit.ly/3ZEyUDk

#HAE #Caregiver #Support #AngioedemaNews #Bionews

#HAE #HAENewsToday #HereditaryAngioedema #ChronicIllnessCommunity #PatientStories #RareDiseaseAwareness #RareDiseaseCommunity #InvisibleIllness #YouTubeChannel #BioNews #AngioedemaNews

#ImmunologyNews Hereditary angioedema (HAE) is a rare inherited disorder characterised by recurrent, unpredictable swelling episodes that can affect the abdomen, limbs, face, genitals, and upper airways...#HAE #immunology

Read more here: https://ow.ly/eiIS50YxqlO

#HAE #HereditaryAngioedema #HaeAwareness #ChronicIllness #RareDisease #StressAwareness #InvisibleIllness #HAECommunity #HealthAdvocacy #BioNews #AngioedemaNews

Donidalorsen Reduces Creatine Kinase and Points to Muscle Instability in HAE Long-term prophylaxis with donidalorsen every 4 weeks significantly reduced creatine kinase in patients with hereditary angioedema.

Long-term prophylaxis with #Donidalorsen administration every 4 weeks was associated with a significant reduction in creatine kinase levels in patients with #HereditaryAngioedema (HAE). Study in World Allergy Organization Journal.

Read more: https://bit.ly/4sgeQDm

#RareDisease #HAE

Argo Biopharma Achieves FDA Fast Track Designation for Novel siRNA Therapy Targeting HAE Argo Biopharmaceutical Co., Ltd. has been awarded FDA Fast Track Designation for BW-20805, a promising siRNA therapy aimed at treating hereditary angioedema (HAE).

Argo Biopharma Achieves FDA Fast Track Designation for Novel siRNA Therapy Targeting HAE #HAE #Argo_Biopharma #BW-20805

Discover Natalie's story: https://bit.ly/4ecE1Ra

She learned firsthand the importance of always having rescue medication ready—and how quickly it can make a difference.

#HAE #HereditaryAngioedema #RescueMedication #ChronicIllness #AngioedemaAwareness #PatientVoice #AngioedemaNews #Bionews

Whether digital or hard copy, her story shows how taking charge of your PHI empowers you, saves time, and makes appointments more effective, especially with rare diseases.

#HAE #Angioedema #RareDisease #AngioedemaNews #Bionews

Finalists Revealed and Host Announced for the Hire Awards of Excellence 2026 - Hire Association Europe

Finalists Revealed for the Hire Awards of Excellence 2026

#HAE #HAEAwards #Awards #HireAssociationEurope #Construction
#GrosvenorTalent

www.hae.org.uk/news-events/...

Discover more: https://bit.ly/4env73h

Besides swelling, HAE can bring fatigue, tingling, rashes, stomach pain, mood changes, and more. Every journey is different.

#Angioedema #HAE #HAESymptoms #HereditaryAngioedema #AngioedemaNews #Bionews

Share below!

#Angioedema #HAE #HereditaryAngioedema #AngioedemaAwareness #AngioedemaNews #Bionews

Here's how HAE forced him to slow down, let go of old expectations, and build a new rhythm that works for his family.

#HAE #Angioedema #RareDisease #AngioedemaNews #Bionews

Stay in the know—and never miss an update! https://bit.ly/3FHecMk

Sign up for the weekly newsletter, because knowledge is power, and you’re not alone!

#Angioedema #HAE #PatientSupport #Newsletter #RareDisease #AngioedemaNews #Bionews

Discover Natalie's story: https://bit.ly/4jZNcWd

Do you get it? Share your experience in the comments.

#Angioedema #HAE #HAEDiagnosis #RareDisease #HAEAwareness #AngioedemaNews #Bionews

Take a moment today to recognize your angioedema progress: https://bit.ly/3Hy0T1m

Whether you’re living with HAE or caring for someone who is, every step forward matters—you’re stronger than you think. 💙 

#Angioedema #HAE #ChronicIllness #RareDisease #AngioedemaNews #Bionews

Discover the latest approved treatments for angioedema: https://bit.ly/4mCCnvR

#Angioedema #HAE #RareDisease #TreatmentOptions #HealthCare #AngioedemaNews #Bionews

7 Allergy Headlines You Missed in February 2026 | HCPLive This month in review features 7 allergy headlines in February 2026: FDA's decision on Dupilumab for AFRS, late-breaking data presented at AAAAI, & more.

Catch up on #allergy news you missed in February, including the #FDA approval of dupilumab for #AFRS, updated pediatric #HAE guidelines that recommend sebetralstat as first-line therapy, & late-breaking data presented at #AAAI26:

Navenibart at 3- and 6-Month Dosing Reduces HAE Attacks, With Adil Adatia, MD | HCPLive Phase 2 ALPHA-SOLAR data presented at AAAAI 2026 show navenibart provides >95% median attack reduction in HAE with favorable safety for 3- and 6-month prophylaxis.

Phase 2 ALPHA-SOLAR data presented at #AAAAI26 show navenibart given every 3 or 6 months reduced #HAE attacks by > 95%. Adil Adatia, MD, discusses how this long-acting kallikrein inhibitor may lower treatment burden:

Follow Hollie's journey: https://bit.ly/4lDaF0K

At 17, she began a nine-year search for answers about her health. 

#HAEDiagnosis #HAE #Angioedema #AngioedemaNews #Bionews

Taking control of HAE starts at home: https://bit.ly/4ns2bLx

With the right training, self-injecting your medication means faster relief, fewer ER trips, and more confidence in managing attacks.

#Angioedema #HAE #HAETreatment #SelfInjection #ChronicIllness #RareDisease #AngioedemaNews #Bionews

Discover Danita's story: https://bit.ly/3TPuuGb

Great caregivers aren’t defined by gender. They’re defined by compassion, patience, and a willingness to show up, especially during tough times.

#Angioedema #AngioedemaCaregiver #ChronicIllness #HAE #RareDisease #AngioedemaNews #Bionews

Some adults living with hereditary angioedema may also experience “emotional blindness”, or difficulty identifying and describing their feelings. It can add another invisible layer to an already unpredictable disease.

#Angioedema #HAE #MentalHealthMatters #AngioedemaNewsToday #Bionews

Dive into Liana's story: https://bit.ly/4lCJK5p

Liana Meffert opens up about how adjusting her eating habits has helped her manage hereditary angioedema (HAE) and other diagnoses. 

#HAE #ChronicIllness #Angioedema #RareDisease #AngioedemaNews #Bionews

Stay in the know—and never miss an update! https://bit.ly/3FHecMk

Sign up for the weekly newsletter, because knowledge is power, and you’re not alone!

#Angioedema #HAE #PatientSupport #Newsletter #RareDisease #AngioedemaNews #Bionews